close 74% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Strona główna・Stock List・Mersana Therapeutics Inc
Search

Mersana Therapeutics Inc

Closed

SectorHealthcare

9.66 -0.82

Strong Buy

Price update 24 paź 2025, 19:58 UTC

BuySell

Overview

Share price change

24h

Current

Min

9.55

Max

9.76

Key metrics

By Trading Economics

Income

-173K

-24M

Sales

302K

3.1M

Profit margin

-795.026

Employees

102

EBITDA

-303K

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+261.96% upside

Dividends

By Dow Jones

Next Earnings

12 lis 2025

Market Stats

By TradingEconomics

Market Cap

22M

52M

Previous open

10.48

Previous close

9.66

News Sentiment

By Acuity

50%

50%

147 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

0.311 / 0.355 Support & Resistance

Mersana Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 sty 2025, 12:00 UTC

Major Market Movers

Mersana Shares Rise on Advances With Breast-Cancer Treatment

DJ

Read

Peer Comparison

Price change

Mersana Therapeutics Inc Forecast

Price Target

By TipRanks

261.96% upside

12 Months Forecast

Average 35.4 USD  261.96%

High 50 USD

Low 17 USD

Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Based on 7 analysts giving stock ratings to Mersana Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

0.311 / 0.355Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

147 / 371 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

JNJ

Johnson and Johnson

190.6

↓-0.77%

ABT

Abbott Laboratories

126.77

↑ +0.33%

MDT

Medtronic PLC

93.77

↓-0.45%

VEEV

Veeva Systems Inc

293.21

↑ +0.68%

A

Agilent Technologies Inc

148.21

↑ +0.39%
help-icon Live chat